ATE71364T1 - Fluor enthaltende vitamin-d2-derivate. - Google Patents

Fluor enthaltende vitamin-d2-derivate.

Info

Publication number
ATE71364T1
ATE71364T1 AT88301081T AT88301081T ATE71364T1 AT E71364 T1 ATE71364 T1 AT E71364T1 AT 88301081 T AT88301081 T AT 88301081T AT 88301081 T AT88301081 T AT 88301081T AT E71364 T1 ATE71364 T1 AT E71364T1
Authority
AT
Austria
Prior art keywords
fluorine
containing vitamin
derivatives
methyl
trifluoromethyl group
Prior art date
Application number
AT88301081T
Other languages
English (en)
Inventor
Yoshiro Kobayashi
Takeo Taguchi
Nobuo Ikekawa
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE71364T1 publication Critical patent/ATE71364T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT88301081T 1987-02-10 1988-02-09 Fluor enthaltende vitamin-d2-derivate. ATE71364T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP62029423A JPS63196556A (ja) 1987-02-10 1987-02-10 含フツ素ビタミンd誘導体
EP88301081A EP0278732B1 (de) 1987-02-10 1988-02-09 Fluor enthaltende Vitamin-D2-Derivate

Publications (1)

Publication Number Publication Date
ATE71364T1 true ATE71364T1 (de) 1992-01-15

Family

ID=12275720

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88301081T ATE71364T1 (de) 1987-02-10 1988-02-09 Fluor enthaltende vitamin-d2-derivate.

Country Status (5)

Country Link
US (1) US5047564A (de)
EP (1) EP0278732B1 (de)
JP (1) JPS63196556A (de)
AT (1) ATE71364T1 (de)
DE (1) DE3867494D1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN171449B (de) * 1990-02-14 1992-10-17 Wisconsin Alumni Res Found
US5696103A (en) * 1995-11-17 1997-12-09 Syntex (U.S.A.) Inc. Method for treating osteoporosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284577A (en) * 1979-02-16 1981-08-18 Sachiko Yamada Novel vitamin D3 derivative and process for preparing the same
US4248791A (en) * 1980-02-04 1981-02-03 Wisconsin Alumni Research Foundation 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
US4521410A (en) * 1984-05-03 1985-06-04 The General Hospital Corporation Vitamin D glycosyl orthoesters
US4613594A (en) * 1984-11-16 1986-09-23 Hoffmann-La Roche Inc. Fluorinated vitamin D3 compounds

Also Published As

Publication number Publication date
EP0278732A1 (de) 1988-08-17
JPS63196556A (ja) 1988-08-15
US5047564A (en) 1991-09-10
DE3867494D1 (de) 1992-02-20
EP0278732B1 (de) 1992-01-08

Similar Documents

Publication Publication Date Title
NO976085D0 (no) Difenylmetylen-piperidin-derivater
NO932442L (no) Anvendelse av 1,3-oksatiolannukleosidanaloger ved behandling av hepatitt b
EP0256503A3 (en) Pyridinecarboxamide derivatives and their use as fungicide
EP0444659A3 (en) A pharmaceutical solution
DK0604657T3 (da) Phosphonsyrediesterderivat
DE69002996D1 (de) Triphenylmethan-Derivate.
DE69121259D1 (de) Beta-Lactam-Verbindungen und ihre Herstellung
ATE71364T1 (de) Fluor enthaltende vitamin-d2-derivate.
EP0555479A4 (de)
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
MX9205408A (es) Metodo para tratar hipertension.
TW275629B (de)
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DK0501442T3 (da) 8-Chlor-benzothiazepin-forbindelse til forebyggelse og behandling af følgerne af cerebral nekrose af nerveceller
EP0443474A3 (en) 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents
FI941850A (fi) Uusi yhdiste, joka on leustroduksiini H, sen valmistus ja terapeuttinen käyttö

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee